KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Capital Expenditures (2016 - 2026)

Amgen has reported Capital Expenditures over the past 18 years, most recently at $712.0 million for Q1 2026.

  • For Q1 2026, Capital Expenditures rose 73.24% year-over-year to $712.0 million; the TTM value through Mar 2026 reached $2.2 billion, up 69.07%, while the annual FY2025 figure was $1.9 billion, 69.53% up from the prior year.
  • Capital Expenditures for Q1 2026 was $712.0 million at Amgen, up from $642.0 million in the prior quarter.
  • Over five years, Capital Expenditures peaked at $712.0 million in Q1 2026 and troughed at $160.0 million in Q3 2022.
  • A 5-year average of $336.1 million and a median of $271.0 million in 2023 define the central range for Capital Expenditures.
  • Biggest five-year swings in Capital Expenditures: crashed 33.88% in 2022 and later soared 81.05% in 2023.
  • Year by year, Capital Expenditures stood at $340.0 million in 2022, then dropped by 26.76% to $249.0 million in 2023, then soared by 49.0% to $371.0 million in 2024, then skyrocketed by 73.05% to $642.0 million in 2025, then grew by 10.9% to $712.0 million in 2026.
  • Business Quant data shows Capital Expenditures for AMGN at $712.0 million in Q1 2026, $642.0 million in Q4 2025, and $436.0 million in Q3 2025.